LGALS9 and type 2 diabetes mellitus: Our results showed that Tim-3 and Galectin-9 blockade recovered IFN-γ and TNF-α production but did not affect CD107a expression, which is consistent with the results that overexpression of Galectin-9 on K562 cells does not affect T2DM NK cell-mediated cytotoxicity.